On November 29, at the finals of the "2024 New Generation AI (Shenzhen) Entrepreneurship and Innovation Competition" co-hosted by the Shenzhen Internet Information Office, Bao'an District People's Government, and NetEase Media, OxTium Technology stood out from over 200 registered projects, including 30 entrepreneurship track projects and 30 innovation track projects, with its GeneLLM large model and AI for BioScience platform. After fierce competition in the 13-strong semi-finals, it ultimately won the second prize! This is not only recognition of OxTium's technological innovation capabilities but also high affirmation of the team's efforts in promoting AI technology to empower the life sciences field.
This competition focused on enterprises and products that have achieved breakthroughs using new-generation AI technologies, covering AI infrastructure, embodied intelligence, intelligent agents, intelligent terminals, and the wide application of AI across industries. The judging panel was impressive, with over 30 partners from leading domestic and international investment institutions, university professors in AI, and industry experts as jury members. Shenzhen Capital Group, Northern Light Venture Capital, Songhe Capital, Lenovo Capital, Mingshi Capital, Gaorong Capital, Joy Capital, InnoAngel Fund, BlueRun Ventures, Fengrui Capital, Meihua Capital, Kunchong Capital, SenseTime Guoxiang Capital, Qingliu Capital, and Dawu Venture Capital served as supporting investment institutions. With strong support and guidance from the organizers, OxTium Technology, leveraging its deep technical accumulation in AI large models and unique insights into life science services, ultimately won the second prize after multiple rounds of competition.
OxTium Technology has always adhered to the original intention of "Exploring the Mysteries of Life with AI Technology", using its independently developed GeneLLM large model as the core technology engine to comprehensively promote the deep integration of life sciences and artificial intelligence. GeneLLM is a high-performance multi-omics large model that supports research needs in multiple disciplines such as biomedicine, bioinformatics, molecular biology, immunology, and molecular dynamics. At the same time, the company has built the one-stop life science service platform BioFord, which integrates the technical advantages of AI and life sciences to provide solutions covering medical diagnosis, disease treatment, biomanufacturing, biological breeding, and environmental monitoring, bringing disruptive changes to the life science research industry.
Competition judges stated that the technological innovation and broad application of OxTium Technology demonstrate the great potential of AI in bioscience research. As a leading innovative technology enterprise in the industry, OxTium Technology is driven by technology, profoundly changing the traditional model of life science research and providing breakthrough research ideas for the diagnosis and treatment of various complex diseases.
In the future, OxTium Technology will continue to dedicate itself to the cross-border integration of AI and life sciences, using AI technology as a tool to provide scientists and industry users with more efficient and precise solutions, helping life science research reach new heights and contributing greater value to social health and technological progress.